To further explore whether GOLPH3 has the potential to act as a therapeutic target for bladder cancer, a nude mouse xenograft model of T24 cells was established, and intratumoral injection with GOLPH3 siRNA#1 was performed in the T24 cells established in the xenograft nude mouse model. Here, GOLPH3 is linked to urinary bladder carcinoma.